These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10421975)

  • 1. Biomarkers, surrogates, and evaluation of therapeutic agents: a proposed solution.
    Sobel BE
    Coron Artery Dis; 1999 Jul; 10(5):339-41. PubMed ID: 10421975
    [No Abstract]   [Full Text] [Related]  

  • 2. There is no women's health crisis.
    Satel SL
    Public Interest; 1998; 130():21-33. PubMed ID: 11658109
    [No Abstract]   [Full Text] [Related]  

  • 3. Biomarkers and Surrogate Endpoints: Developing Common Terminology and Definitions.
    Robb MA; McInnes PM; Califf RM
    JAMA; 2016 Mar; 315(11):1107-8. PubMed ID: 26978201
    [No Abstract]   [Full Text] [Related]  

  • 4. NIH panel may increase gene-trial scrutiny..
    Smaglik P
    Nature; 2000 Jun; 405(6788):724. PubMed ID: 10866166
    [No Abstract]   [Full Text] [Related]  

  • 5. US policy keeps drugs out of reach in clinical trials abroad.
    Check E
    Nat Med; 2005 May; 11(5):460. PubMed ID: 15875037
    [No Abstract]   [Full Text] [Related]  

  • 6. Mandating research with children.
    Baylis F
    IRB; 1999; 21(1):10-1. PubMed ID: 11657966
    [No Abstract]   [Full Text] [Related]  

  • 7. RU 486: medical breakthrough held hostage.
    Richards C; Gold RB
    Issues Sci Technol; 1990; 6(4):74-8. PubMed ID: 11650971
    [No Abstract]   [Full Text] [Related]  

  • 8. The concept of the IRB and bureaucratic reality: an exchange of letters.
    van Eys J; Levine RJ
    IRB; 1984; 6(4):8-10. PubMed ID: 11649563
    [No Abstract]   [Full Text] [Related]  

  • 9. No moratorium on clinical trials.
    Vogel G
    Science; 1998 Jan; 279(5351):648. PubMed ID: 9471725
    [No Abstract]   [Full Text] [Related]  

  • 10. Proposal for a coordinated framework for regulation of biotechnology.
    U.S. Office of Science and Technology Policy
    Fed Regist; 1984 Dec; 49(252):50856-907. PubMed ID: 11655658
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA cracks down on labeling, initiates trial result reporting.
    Osborne R; Waltz E
    Nat Biotechnol; 2008 Nov; 26(11):1203-4. PubMed ID: 18997742
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings of the National Conference on Clinical Trials Methodology.
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):629-766. PubMed ID: 35299
    [No Abstract]   [Full Text] [Related]  

  • 13. The Food and Drug Administration's role in the protection of human subjects.
    Nightingale SL
    IRB; 1983; 5(1):6-9. PubMed ID: 11649511
    [No Abstract]   [Full Text] [Related]  

  • 14. Coordinated framework for regulation of biotechnology; establishment of the Biotechnology Science Coordinating Committee; notice.
    U.S. Office of Science and Technology Policy
    Fed Regist; 1985 Nov; 50(220):47174-95. PubMed ID: 11655733
    [No Abstract]   [Full Text] [Related]  

  • 15. Coordinated framework for regulation of biotechnology; announcement of policy; notice for public comment.
    U.S. Office of Science and Technology Policy
    Fed Regist; 1986 Jun; 51(123):23302-50. PubMed ID: 11655807
    [No Abstract]   [Full Text] [Related]  

  • 16. Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop.
    De Gruttola VG; Clax P; DeMets DL; Downing GJ; Ellenberg SS; Friedman L; Gail MH; Prentice R; Wittes J; Zeger SL
    Control Clin Trials; 2001 Oct; 22(5):485-502. PubMed ID: 11578783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulating biotechnology.
    McGarity TO
    Issues Sci Technol; 1985; 1(3):40-56. PubMed ID: 11649701
    [No Abstract]   [Full Text] [Related]  

  • 18. Panel seeks better monitoring of experiments using people.
    Hilts PJ
    N Y Times Web; 2000 Mar; ():A20. PubMed ID: 11873787
    [No Abstract]   [Full Text] [Related]  

  • 19. Macro trends in pharmaceutical innovation.
    Cohen FJ
    Nat Rev Drug Discov; 2005 Jan; 4(1):78-84. PubMed ID: 15688075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why NIH is wrong about "TMD".
    Dawson PE
    Cranio; 1997 Jan; 15(1):1-3. PubMed ID: 9586482
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.